Mechanisms of neurodegeneration in amyotrophic lateral sclerosis

被引:0
|
作者
Cluskey, S [1 ]
Ramsden, DB [1 ]
机构
[1] Univ Birmingham, Queen Elizabeth Hosp, Dept Med, Birmingham B15 2TH, W Midlands, England
来源
关键词
amyotrophic lateral sclerosis; motor neurone disease; neurodegeneration;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Amyotrophic lateral sclerosis (ALS) is the most common variant of motor neurone disease affecting adults that usually strikes during mid to late life. Its aetiology is still poorly understood, although a major breakthrough came with the discovery that mutations in the Cu/Zn superoxide dismutase (SOD1) gene affect approximately 20% of patients with familial ALS. Experiments using both transgenic mice and ALS tissues have been useful in delineating other genetic defects in ALS. However, because only a subset of cases can be attributed to one particular molecular defect (such as mutation of SOD1 or the gene encoding neurofilament H), the aetiology of ALS is likely to be multifactorial. This review discusses the major mechanisms of neurodegeneration in ALS, such as oxidative stress, glutaminergic excitotoxicity, damage to vital organelles, and aberrant protein aggregation.
引用
收藏
页码:386 / 392
页数:7
相关论文
共 50 条
  • [1] Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis
    Rothstein, JD
    CLINICAL NEUROSCIENCE, 1996, 3 (06) : 348 - 359
  • [2] Phenotypic heterogeneity in amyotrophic lateral sclerosis type 8 and modifying mechanisms of neurodegeneration
    Oliveira, Danyllo
    Verjovski-Almeida, Sergio
    Zatz, Mayana
    NEURAL REGENERATION RESEARCH, 2021, 16 (09) : 1776 - 1778
  • [3] Phenotypic heterogeneity in amyotrophic lateral sclerosis type 8 and modifying mechanisms of neurodegeneration
    Danyllo Oliveira
    Sergio Verjovski-Almeida
    Mayana Zatz
    Neural Regeneration Research, 2021, 16 (09) : 1776 - 1778
  • [4] Molecular Biomarkers of Neurodegeneration in Amyotrophic Lateral Sclerosis
    Denis V. Shevchuk
    Amir I. Tukhvatulin
    Alina S. Dzharullaeva
    Irina A. Berdalina
    Maria N. Zakharova
    Biochemistry (Moscow), 2025, 90 (2) : 276 - 288
  • [5] Pathophysiology of Neurodegeneration in Familial Amyotrophic Lateral Sclerosis
    Vucic, Steve
    Kiernan, Matthew C.
    CURRENT MOLECULAR MEDICINE, 2009, 9 (03) : 255 - 272
  • [6] Ascorbate availability and neurodegeneration in amyotrophic lateral sclerosis
    Kok, AB
    MEDICAL HYPOTHESES, 1997, 48 (04) : 281 - 296
  • [7] Strategies for clinical approach to neurodegeneration in amyotrophic lateral sclerosis
    Carlesi, C.
    Pasquali, L.
    Piazza, S.
    Lo Gerfo, A.
    Ienco, E. Caldarazzo
    Alessi, R.
    Fornai, F.
    Siciliano, G.
    ARCHIVES ITALIENNES DE BIOLOGIE, 2011, 149 (01): : 151 - 167
  • [8] Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis
    Sami J. Barmada
    Neurotherapeutics, 2015, 12 : 340 - 351
  • [9] Exosomal Transport and Progression of Neurodegeneration in Amyotrophic Lateral Sclerosis
    Ivanova, M. V.
    Chekanova, E. O.
    Belugin, B. V.
    Tutykhina, I. L.
    Dolzhikova, I. V.
    Zakroishchikova, I. V.
    Vasil'ev, A. V.
    Zakharova, M. N.
    NEUROCHEMICAL JOURNAL, 2019, 13 (03) : 229 - 239
  • [10] Hyperexcitability, neurodegeneration, and disease progression in amyotrophic lateral sclerosis
    Kiernan, Matthew C. C.
    Park, Susanna B. B.
    MUSCLE & NERVE, 2023, 68 (02) : 103 - 105